Insider · CIK 0002024211
Kaan Certel
Files at OMGA (Omega Therapeutics, Inc.). First filing -, latest -.
Kaan Certel files SEC Form 4 as officer and director at OMGA (Omega Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kaan Certel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | OMGA Omega Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +340,000 | $0.00 | $0 | 340,000 | Nov 15, 2024 |
Questions about Kaan Certel
Answered from the filings on this page, as of the latest one.
Is Kaan Certel buying or selling?
Kaan Certel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kaan Certel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kaan Certel has 0.
Where does Kaan Certel file Form 4?
Kaan Certel has filed Form 4 at OMGA (Omega Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.